blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3160444

EP3160444 - A PHARMACEUTICAL OIL-IN-WATER NANO-EMULSION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  30.09.2022
Database last updated on 08.04.2026
FormerThe patent has been granted
Status updated on  22.10.2021
FormerGrant of patent is intended
Status updated on  10.06.2021
FormerExamination is in progress
Status updated on  17.12.2019
FormerRequest for examination was made
Status updated on  31.03.2017
FormerThe international publication has been made
Status updated on  14.12.2016
Most recent event   Tooltip19.12.2025Lapse of the patent in a contracting state
New state(s): TR		published on 21.01.2026  [2026/04]
Applicant(s)For all designated states
Synergia Bio Sciences Private Limited
Embassy Diamante
34 Vittal Mallya Road
Bangalore 560001 / IN
[2017/18]
Inventor(s)01 / MISRA, Ambikanandan
The Maharaja Sayajirao University of Baroda
Post Box No.: 51
Kalabhavan
Vadodara 390001 / IN
 [2017/18]
Representative(s)CSY London
Helios Court
1 Bishop Square
Hatfield
Hertfordshire AL10 9NE / GB
[N/P]
Former [2021/47]CSY London
10 Fetter Lane
London EC4A 1BR / GB
Former [2017/18]Cleveland
10 Fetter Lane
London EC4A 1BR / GB
Application number, filing date15757010.225.06.2015
[2017/18]
WO2015IN00266
Priority number, dateIN2014CHE307725.06.2014         Original published format: IN 3077CH2014
[2017/18]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015198350
Date:30.12.2015
Language:EN
[2015/52]
Type: A1 Application with search report 
No.:EP3160444
Date:03.05.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 30.12.2015 takes the place of the publication of the European patent application.
[2017/18]
Type: B1 Patent specification 
No.:EP3160444
Date:24.11.2021
Language:EN
[2021/47]
Search report(s)International search report - published on:EP30.12.2015
ClassificationIPC:A61K9/00, A61K47/10, A61K47/12, A61K47/14, A61K47/26, A61K9/107, A61K47/44, A61K31/167, A61K31/4178, A61K31/519, A61K31/551
[2017/18]
CPC:
A61K9/1075 (EP,US); A61K31/167 (EP,US); A61K31/4178 (EP,US);
A61K31/519 (EP,US); A61K31/551 (EP,US); A61K47/10 (EP,US);
A61K47/12 (EP,US); A61K47/14 (EP,US); A61K47/22 (US);
A61K47/26 (EP,US); A61K47/44 (EP,US); A61K9/0043 (EP,US);
A61K9/0048 (EP,US); A61P1/08 (EP); A61P25/04 (EP);
A61P25/06 (EP); A61P25/18 (EP); A61P25/20 (EP);
A61P27/02 (EP); A61P27/06 (EP); A61P29/00 (EP);
A61P29/02 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/18]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
TitleGerman:PHARMAZEUTISCHE ÖL-IN-WASSER-NANOEMULSION[2017/18]
English:A PHARMACEUTICAL OIL-IN-WATER NANO-EMULSION[2017/18]
French:NANO ÉMULSION PHARMACEUTIQUE HUILE-DANS-EAU[2017/18]
Entry into regional phase14.12.2016National basic fee paid 
14.12.2016Designation fee(s) paid 
14.12.2016Examination fee paid 
Examination procedure14.12.2016Examination requested  [2017/18]
14.12.2016Date on which the examining division has become responsible
26.07.2017Amendment by applicant (claims and/or description)
20.12.2019Despatch of a communication from the examining division (Time limit: M04)
01.04.2020Reply to a communication from the examining division
23.07.2020Despatch of a communication from the examining division (Time limit: M04)
20.10.2020Reply to a communication from the examining division
18.02.2021Despatch of a communication from the examining division (Time limit: M02)
16.04.2021Reply to a communication from the examining division
11.06.2021Communication of intention to grant the patent
13.10.2021Fee for grant paid
13.10.2021Fee for publishing/printing paid
13.10.2021Receipt of the translation of the claim(s)
Opposition(s)25.08.2022No opposition filed within time limit [2022/44]
Fees paidRenewal fee
28.06.2017Renewal fee patent year 03
19.12.2018Renewal fee patent year 04
28.06.2019Renewal fee patent year 05
29.06.2020Renewal fee patent year 06
30.06.2021Renewal fee patent year 07
Penalty fee
Additional fee for renewal fee
30.06.201804   M06   Fee paid on   19.12.2018
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU25.06.2015
AL24.11.2021
AT24.11.2021
CY24.11.2021
CZ24.11.2021
DK24.11.2021
EE24.11.2021
ES24.11.2021
FI24.11.2021
HR24.11.2021
IT24.11.2021
LT24.11.2021
LV24.11.2021
MC24.11.2021
MK24.11.2021
MT24.11.2021
NL24.11.2021
PL24.11.2021
RO24.11.2021
RS24.11.2021
SE24.11.2021
SI24.11.2021
SK24.11.2021
SM24.11.2021
TR24.11.2021
BG24.02.2022
NO24.02.2022
GR25.02.2022
IS24.03.2022
PT24.03.2022
LU25.06.2022
BE30.06.2022
[2026/04]
Former [2024/42]HU25.06.2015
AL24.11.2021
AT24.11.2021
CY24.11.2021
CZ24.11.2021
DK24.11.2021
EE24.11.2021
ES24.11.2021
FI24.11.2021
HR24.11.2021
IT24.11.2021
LT24.11.2021
LV24.11.2021
MC24.11.2021
MK24.11.2021
MT24.11.2021
NL24.11.2021
PL24.11.2021
RO24.11.2021
RS24.11.2021
SE24.11.2021
SI24.11.2021
SK24.11.2021
SM24.11.2021
BG24.02.2022
NO24.02.2022
GR25.02.2022
IS24.03.2022
PT24.03.2022
LU25.06.2022
BE30.06.2022
Former [2024/22]HU25.06.2015
AL24.11.2021
AT24.11.2021
CY24.11.2021
CZ24.11.2021
DK24.11.2021
EE24.11.2021
ES24.11.2021
FI24.11.2021
HR24.11.2021
IT24.11.2021
LT24.11.2021
LV24.11.2021
MC24.11.2021
MK24.11.2021
NL24.11.2021
PL24.11.2021
RO24.11.2021
RS24.11.2021
SE24.11.2021
SI24.11.2021
SK24.11.2021
SM24.11.2021
BG24.02.2022
NO24.02.2022
GR25.02.2022
IS24.03.2022
PT24.03.2022
LU25.06.2022
BE30.06.2022
Former [2024/20]HU25.06.2015
AL24.11.2021
AT24.11.2021
CY24.11.2021
CZ24.11.2021
DK24.11.2021
EE24.11.2021
ES24.11.2021
FI24.11.2021
HR24.11.2021
IT24.11.2021
LT24.11.2021
LV24.11.2021
MC24.11.2021
NL24.11.2021
PL24.11.2021
RO24.11.2021
RS24.11.2021
SE24.11.2021
SI24.11.2021
SK24.11.2021
SM24.11.2021
BG24.02.2022
NO24.02.2022
GR25.02.2022
IS24.03.2022
PT24.03.2022
LU25.06.2022
BE30.06.2022
Former [2024/18]HU25.06.2015
AL24.11.2021
AT24.11.2021
CZ24.11.2021
DK24.11.2021
EE24.11.2021
ES24.11.2021
FI24.11.2021
HR24.11.2021
IT24.11.2021
LT24.11.2021
LV24.11.2021
MC24.11.2021
NL24.11.2021
PL24.11.2021
RO24.11.2021
RS24.11.2021
SE24.11.2021
SI24.11.2021
SK24.11.2021
SM24.11.2021
BG24.02.2022
NO24.02.2022
GR25.02.2022
IS24.03.2022
PT24.03.2022
LU25.06.2022
BE30.06.2022
Former [2023/25]AL24.11.2021
AT24.11.2021
CZ24.11.2021
DK24.11.2021
EE24.11.2021
ES24.11.2021
FI24.11.2021
HR24.11.2021
IT24.11.2021
LT24.11.2021
LV24.11.2021
MC24.11.2021
NL24.11.2021
PL24.11.2021
RO24.11.2021
RS24.11.2021
SE24.11.2021
SI24.11.2021
SK24.11.2021
SM24.11.2021
BG24.02.2022
NO24.02.2022
GR25.02.2022
IS24.03.2022
PT24.03.2022
LU25.06.2022
BE30.06.2022
Former [2023/21]AL24.11.2021
AT24.11.2021
CZ24.11.2021
DK24.11.2021
EE24.11.2021
ES24.11.2021
FI24.11.2021
HR24.11.2021
LT24.11.2021
LV24.11.2021
MC24.11.2021
NL24.11.2021
PL24.11.2021
RO24.11.2021
RS24.11.2021
SE24.11.2021
SI24.11.2021
SK24.11.2021
SM24.11.2021
BG24.02.2022
NO24.02.2022
GR25.02.2022
IS24.03.2022
PT24.03.2022
LU25.06.2022
Former [2023/08]AL24.11.2021
AT24.11.2021
CZ24.11.2021
DK24.11.2021
EE24.11.2021
ES24.11.2021
FI24.11.2021
HR24.11.2021
LT24.11.2021
LV24.11.2021
MC24.11.2021
NL24.11.2021
PL24.11.2021
RO24.11.2021
RS24.11.2021
SE24.11.2021
SI24.11.2021
SK24.11.2021
SM24.11.2021
BG24.02.2022
NO24.02.2022
GR25.02.2022
IS24.03.2022
PT24.03.2022
Former [2023/01]AL24.11.2021
AT24.11.2021
CZ24.11.2021
DK24.11.2021
EE24.11.2021
ES24.11.2021
FI24.11.2021
HR24.11.2021
LT24.11.2021
LV24.11.2021
NL24.11.2021
PL24.11.2021
RO24.11.2021
RS24.11.2021
SE24.11.2021
SI24.11.2021
SK24.11.2021
SM24.11.2021
BG24.02.2022
NO24.02.2022
GR25.02.2022
IS24.03.2022
PT24.03.2022
Former [2022/49]AL24.11.2021
AT24.11.2021
CZ24.11.2021
DK24.11.2021
EE24.11.2021
ES24.11.2021
FI24.11.2021
HR24.11.2021
LT24.11.2021
LV24.11.2021
NL24.11.2021
PL24.11.2021
RO24.11.2021
RS24.11.2021
SE24.11.2021
SK24.11.2021
SM24.11.2021
BG24.02.2022
NO24.02.2022
GR25.02.2022
IS24.03.2022
PT24.03.2022
Former [2022/35]AT24.11.2021
CZ24.11.2021
DK24.11.2021
EE24.11.2021
ES24.11.2021
FI24.11.2021
HR24.11.2021
LT24.11.2021
LV24.11.2021
NL24.11.2021
PL24.11.2021
RO24.11.2021
RS24.11.2021
SE24.11.2021
SK24.11.2021
SM24.11.2021
BG24.02.2022
NO24.02.2022
GR25.02.2022
IS24.03.2022
PT24.03.2022
Former [2022/34]AT24.11.2021
EE24.11.2021
ES24.11.2021
FI24.11.2021
HR24.11.2021
LT24.11.2021
LV24.11.2021
NL24.11.2021
PL24.11.2021
RO24.11.2021
RS24.11.2021
SE24.11.2021
SM24.11.2021
BG24.02.2022
NO24.02.2022
GR25.02.2022
IS24.03.2022
PT24.03.2022
Former [2022/33]AT24.11.2021
ES24.11.2021
FI24.11.2021
HR24.11.2021
LT24.11.2021
LV24.11.2021
NL24.11.2021
PL24.11.2021
RS24.11.2021
SE24.11.2021
SM24.11.2021
BG24.02.2022
NO24.02.2022
GR25.02.2022
IS24.03.2022
PT24.03.2022
Former [2022/25]AT24.11.2021
ES24.11.2021
FI24.11.2021
HR24.11.2021
LT24.11.2021
LV24.11.2021
NL24.11.2021
PL24.11.2021
RS24.11.2021
SE24.11.2021
BG24.02.2022
NO24.02.2022
GR25.02.2022
IS24.03.2022
PT24.03.2022
Former [2022/24]AT24.11.2021
ES24.11.2021
FI24.11.2021
HR24.11.2021
LT24.11.2021
LV24.11.2021
NL24.11.2021
PL24.11.2021
RS24.11.2021
SE24.11.2021
BG24.02.2022
GR25.02.2022
IS24.03.2022
PT24.03.2022
Former [2022/23]AT24.11.2021
ES24.11.2021
FI24.11.2021
HR24.11.2021
LT24.11.2021
LV24.11.2021
PL24.11.2021
RS24.11.2021
BG24.02.2022
PT24.03.2022
Former [2022/22]AT24.11.2021
FI24.11.2021
LT24.11.2021
RS24.11.2021
BG24.02.2022
Former [2022/21]AT24.11.2021
RS24.11.2021
BG24.02.2022
Former [2022/19]BG24.02.2022
Cited inInternational search[XI] WO9956727  (ELAN CORP PLC et al.) [X] 1,2,6,10,11,13,22 * the whole document * * page 11, line 27 - page 12, line 19; examples 1,18; claim - *[I] 3-5,7-9,12,14-21
 [A]   MUKESH KUMAR ET AL: "Mucoadhesive nanoemulsion-based intranasal drug delivery system of olanzapine for brain targeting", JOURNAL OF DRUG TARGETING., vol. 16, no. 10, January 2008 (2008-01-01), DE, pages 806 - 814, XP055229726, ISSN: 1061-186X, DOI: 10.1080/10611860802476504 [A] 1-22 * the whole document *

DOI:   http://dx.doi.org/10.1080/10611860802476504
 [A]   KUMAR M ET AL: "Intranasal nanoemulsion based brain targeting drug delivery system of risperidone", INTERNATIONAL JOURNAL OF PHARMACEUTICS, ELSEVIER BV, NL, vol. 358, no. 1-2, 24 June 2008 (2008-06-24), pages 285 - 291, XP022698740, ISSN: 0378-5173, [retrieved on 20080327], DOI: 10.1016/J.IJPHARM.2008.03.029 [A] 1-22 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.ijpharm.2008.03.029
 [A]   GURSOY R N ET AL: "Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs", BIOMEDICINE AND PHARMACOTHERAPY, ELSEVIER, FR, vol. 58, no. 3, April 2004 (2004-04-01), pages 173 - 182, XP002500493, ISSN: 0753-3322, DOI: 10.1016/J.BIOPHA.2004.02.001 [A] 1-22 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.biopha.2004.02.001
Examination  RASHMIN B PATEL ET AL: "Formulation and Evaluation of Microemulsions-Based Drug Delivery System for Intranasal Administration of Olanzapine", INTERNATIONAL JOURNAL OF BIOMEDICAL AND PHARMACEUTICAL SCIENCES, vol. 7, no. 1, 2013, pages 20 - 27, XP055651586 [I] 1-15
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.